Company Filing History:
1 out of 257 
1 out of 13 Years Active: 2022
Title: Koubun Yasuda: Innovator in Therapeutic Agents for Endometriosis
Introduction
Koubun Yasuda is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of medical therapeutics, particularly in the treatment of endometriosis and adenomyosis. His innovative work has led to the development of a therapeutic agent that targets IL-33, a key factor in these conditions.
Latest Patents
Koubun Yasuda holds a patent for an IL-33 antagonist-containing therapeutic agent for endometriosis. This invention is based on the identification of IL-33 as an exacerbating factor in endometriosis and adenomyosis uteri. The therapeutic agent is capable of inhibiting the function of IL-33, making it useful for treating, preventing, or alleviating these conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Yasuda has worked with prominent organizations, including Mitsubishi Tanabe Pharma Corporation and Hyogo College of Medicine. His experience in these institutions has allowed him to advance his research and contribute to the development of effective treatments for endometriosis.
Collaborations
Koubun Yasuda has collaborated with several professionals in his field, including Tomohiro Yoshimoto and Joseph M Palumbo. These collaborations have enriched his research and have been instrumental in the progress of his innovative projects.
Conclusion
Koubun Yasuda's work in developing therapeutic agents for endometriosis showcases his dedication to improving women's health. His innovative approach to targeting IL-33 has the potential to make a significant impact in the treatment of these conditions.